The management of male idiopathic infertility is heterogeneous. Although meta-analyses reported the effectiveness on pregnancy rate, the real clinical impact of follicle-stimulating hormone (FSH) was not evaluated so far. In Italy, FSH is approved by the national Medicines Agency (AIFA) for idiopathic infertile patients with FSH < 8 IU/L, independently of semen parameters.
Use of follicle-stimulating hormone (FSH) for the male partner of idiopathic infertile couples in Italy: Results from a multicentre, observational, clinical practice survey / Santi, Daniele; De Vincentis, Sara; Alfano, Patrizia; Balercia, Giancarlo; Calogero, Aldo E; Cargnelutti, Francesco; Coccia, Maria Elisabetta; Condorelli, Rosita A; Dal Lago, Alessandro; De Angelis, Cristina; Gallo, Mariagrazia; Iannantuoni, Nicola; Lombardo, Francesco; Marino, Angelo; Mazzella, Marco; Pallotti, Francesco; Paoli, Donatella; Pivonello, Rosario; Rago, Rocco; Rampini, Mariarita; Salvio, Gianmaria; Simoni, Manuela. - In: ANDROLOGY. - ISSN 2047-2919. - 8:3(2020), pp. 637-644. [10.1111/andr.12748]
Use of follicle-stimulating hormone (FSH) for the male partner of idiopathic infertile couples in Italy: Results from a multicentre, observational, clinical practice survey
Santi, Daniele;De Vincentis, Sara;Simoni, Manuela
2020
Abstract
The management of male idiopathic infertility is heterogeneous. Although meta-analyses reported the effectiveness on pregnancy rate, the real clinical impact of follicle-stimulating hormone (FSH) was not evaluated so far. In Italy, FSH is approved by the national Medicines Agency (AIFA) for idiopathic infertile patients with FSH < 8 IU/L, independently of semen parameters.File | Dimensione | Formato | |
---|---|---|---|
Andrology - 2019 - Santi - Use of follicle‐stimulating hormone for the male partner of idiopathic infertile couples in.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
741.24 kB
Formato
Adobe PDF
|
741.24 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris